All participants in the Phase 3 clinical trial of Taiwan-based Medigen Vaccine Biologics Corp.'s COVID-19 vaccine in Paraguay have now received two shots of either the Medigen or AstraZeneca vaccine, the company said Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
2 acquitted of endangering flights with drone near Taoyuan Airport
12/23/2024 12:53 PM - Business
Taiwan plans to raise duty-free limit for alcohol to 1.5 liters: MOF
12/23/2024 12:38 PM - Society
Low of 7.3°C recorded Monday in Sanwan amid cold, wet weather
12/23/2024 10:54 AM - Business
U.S. dollar lower in Taipei trading
12/23/2024 10:12 AM - Society
Taiwan headline news
12/23/2024 10:07 AM